Low dose continuous chemotherapy (LD56): an active treatment with low toxicity for patients with recurrent/refractory lymphoma not eligible for intensive salvage therapy

Br J Haematol. 2009 Nov;147(3):408-10. doi: 10.1111/j.1365-2141.2009.07847.x. Epub 2009 Aug 2.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Contraindications
  • Drug Administration Schedule
  • Female
  • Humans
  • Lymphoma / drug therapy*
  • Male
  • Middle Aged
  • Palliative Care / methods
  • Salvage Therapy
  • Young Adult